Document is current
Any future updates will be listed below
-
Authors
Nziza, Nadège
Deng, Yixiang
Wood, Lianna http://orcid.org/0000-0001-9531-5627
Dhanoa, Navneet http://orcid.org/0000-0003-1020-8430
Dulit-Greenberg, Naomi
Chen, Tina http://orcid.org/0000-0002-8474-7958
Kane, Abigail S.
Swank, Zoe
Davis, Jameson P. http://orcid.org/0000-0003-2530-2606
Demokritou, Melina
Chitnis, Anagha P.
Fasano, Alessio http://orcid.org/0000-0002-2134-0261
Edlow, Andrea G. http://orcid.org/0000-0003-2915-5949
Jain, Nitya
Horwitz, Bruce H. http://orcid.org/0000-0002-8123-8728
McNamara, Ryan P.
Walt, David R. http://orcid.org/0000-0002-5524-7348
Lauffenburger, Douglas A. http://orcid.org/0000-0002-0050-989X
Julg, Boris http://orcid.org/0000-0002-4687-9626
Shreffler, Wayne G. http://orcid.org/0000-0001-6465-137X
Alter, Galit
Yonker, Lael M. http://orcid.org/0000-0003-1711-8227
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1146996)
- License Information
-
More Information
Article History
Received: 28 March 2023
Accepted: 17 January 2024
First Online: 30 January 2024
Competing interests
: G.A. is a V.P. at Moderna, a founder and equity holder of Seromyx Systems, and an employee and equity holder of Leyden Labs. G.A.’s interests were reviewed and are managed by MGH and Partners HealthCare by their conflict-of-interest policies. All other authors declare that they have no competing interests.
